Clinical Trial

Mass Spectrometry-based Immune Profiling in Autoimmune Diseases

Name: Mass Spectrometry-based Immune Profiling in Autoimmune Diseases — clinical trial record (NCT07188285)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Based on mass spectrometry flow method, this study analyzed the typing of new T, B, NK and DC cell subsets in peripheral blood of common autoimmune diseases and their correlation with disease activity, aiming at establishing an early screening and diagnosis model of autoimmune diseases.

Trial Details

NCT Number	NCT07188285
Lead Sponsor	Peking University People's Hospital Collaborators: National Natural Science Foundation of China, Zhejiang PuLuoTing Health Technology Co., Ltd.
Conditions	Systemic Lupus Erthematosus, Sjogren's Syndrome, Inflammatory Myopathies, Systemic Sclerosis (SSc), Vasculitis, Rheumatoid Arthritis (RA), Ankylosing Spondylitis, Osteoarthritis +3 more
Enrollment	500 participants
Start Date	2025-09-16
Primary Completion	2026-09-30 (estimated)
Study Completion	2026-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-09-23